Gene-by-gene interactions associated with the risk of conotruncal heart defects by Lyu, Chen et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
1-1-2020 
Gene-by-gene interactions associated with the risk of conotruncal 
heart defects 
Chen Lyu 
Daniel M Webber 
Stewart L MacLeod 
Charlotte A Hobbs 
Ming Li 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Chen Lyu, Daniel M Webber, Stewart L MacLeod, Charlotte A Hobbs, Ming Li, and National Birth Defects 
Prevention Study 
Mol Genet Genomic Med. 2020;8:e1010.    |  1 of 13
https://doi.org/10.1002/mgg3.1010
wileyonlinelibrary.com/journal/mgg3
1 |  INTRODUCTION
Congenital heart defects (CHDs) are the most common type 
of birth defects, affecting 48.9 million people globally in 2015 
(Vos et al., 2016). The prevalence of disease is approximately 
1% (Vos et al., 2015), contributing to ~300,000 infant deaths 
per year (Naghavi et al., 2015; Wang et al., 2016). Children 
with CHDs are usually at increased risks of other health con-
ditions, such as developmental disabilities (Limperopoulos et 
al., 2000; Razzaghi, Oster, & Reefhuis, 2015) and cognitive 
disorders (Shillingford et al., 2008). CHDs comprise vari-
ous cardiac anomalies that are etiologically heterogeneous. 
Conotruncal heart defects (CTDs), such as tetralogy of Fallot, 
truncus arteriosus, double outlet right ventricle, transposition 
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Abstract
Background: The development of conotruncal heart defects (CTDs) involves a com-
plex relationship among genetic variants and maternal lifestyle factors. In this article, 
we focused on the interactions between 13 candidate genes within folate, homocyst-
eine, and transsulfuration pathways for potential association with CTD risk.
Methods: Targeted sequencing was used for 328 case‐parental triads enrolled in 
the National Birth Defects Prevention Study (NBDPS). To evaluate the interac-
tion of two genes, we applied a conditional logistic regression model for all pos-
sible SNP pairs within two respective genes by contrasting the affected infants with 
their pseudo‐controls. The findings were replicated in an independent sample of 86 
NBDPS case‐parental triads genotyped by DNA microarrays. The results of two 
studies were further integrated by a fixed‐effect meta‐analysis.
Results: One SNP pair (i.e., rs4764267 and rs6556883) located in gene MGST1 and 
GLRX, respectively, was found to be associated with CTD risk after multiple testing 
adjustment using simpleM, a modified Bonferroni correction approach (nominal p‐
value of 4.62e‐06; adjusted p‐value of .04). Another SNP pair (i.e., rs11892646 and 
rs56219526) located in gene DNMT3A and MTRR, respectively, achieved marginal 
significance after multiple testing adjustment (adjusted p‐value of .06).
Conclusion: Further studies with larger sample sizes are needed to confirm and elu-
cidate these potential interactions.
K E Y W O R D S
case‐parental triads, conditional logistic regression, conotroncal heart defects, gene‐by‐gene interaction, 
meta‐analysis, single nucleotide polymorphism
2 of 13 |   LYU et aL.
of the great arteries, pulmonary atresia, malalignment ven-
tricle septal defect, and interrupted aortic arch type B, are a 
major and severe subtype of CHDs, accounting for 20%–30% 
of all CHD cases (Botto, Lin, Riehle‐Colarusso, Malik, & 
Correa, 2007; Kuehl & Loffredo, 2005). With the advance 
of surgical therapy and medical care, the survival rate of 
CTD‐affected infants has improved substantially over the 
past 50 years (Oster et al., 2013). However, those infants who 
survived may require repeated surgeries and continuing med-
ical care into their adulthood (Gilboa et al., 2016), imposing 
enormous emotional and financial burden to their families 
and the health care system (McClung, Glidewell, & Farr, 
2018; Simeone et al., 2014). Understanding the pathogenesis 
of CTDs is of crucial importance to reduce the public health 
impact of the disease.
Previous studies have identified a number of risk factors, 
such as maternal obesity (Brite, Laughon, Troendle, & Mills, 
2014; Gilboa et al., 2010), diabetes (Lisowski et al., 2010; 
Stavsky et al., 2017), tobacco use (Alverson, Strickland, 
Gilboa, & Correa, 2011; Malik et al., 2008), and medica-
tion use (Li et al., 2014a, 2014b) during pregnancy. Genetic 
variants have also been identified for association with dis-
ease susceptibility. For example, the microdeletion on the 
long arm of chromosome 22 (i.e., DiGeorge syndrome) 
substantially increases the disease risk, and may account 
for ~12% of conotruncal malformations (Hacihamdioglu, 
Hacihamdioglu, & Delil, 2015; Liu et al., 2014). Other chro-
mosomal abnormalities and copy number variations, such as 
1q21, 8p23, and11q25 (Edwards & Gelb, 2016; Thienpont 
et al., 2007), may also increase the risk of CTDs. In addi-
tion, previous studies have shown that multiple genes, such 
as NKX2.5, GATA4, GATA6, TBX1, TBX5, CITED2, HAND2, 
NOTCH1, JAG1, ACTC1, and THRAP2, are associated with 
the transcription factors, ligands‐receptors, contractile and 
miscellaneous proteins that are involved in essential cardiac 
developmental processes (Hu et al., 2013; Huang et al., 2010; 
Li, Pu, Liu, Xu, & Xu, 2017; Wessels & Willems, 2010; 
Zhang, Hong, et al., 2018a). In recent years, genetic asso-
ciation studies have identified additional genes from vari-
ous biological pathways, such as folic acid, homocysteine, 
and transsulfuration, for potential association with CTD risk 
(Hobbs et al., 2014; Shaw et al., 2005, 2009). However, these 
genes generally have small to intermediate effect sizes, and 
collectively may only explain a small proportion of CTDs 
cases (Fahed, Gelb, Seidman, & Seidman, 2013). The etiol-
ogy of CTDs is highly complex, involving multiple genetic 
variants, maternal environmental exposures and lifestyle fac-
tors (Gelb & Chung, 2014; Pierpont et al., 2007).
To date, most studies have adopted a single‐locus anal-
ysis strategy, by testing each single genetic variant for po-
tential association with the disease. However, accumulating 
evidence has demonstrated that gene‐by‐gene interaction ex-
ists pervasively in biological pathways and may be a major 
source of the unexplained disease heritability (Eichler et al., 
2010; Moore, 2003). For example, an animal study analyzed 
the transcriptome data among mouse embryos with various 
combinations of wild‐type and mutant genotypes. The results 
suggested that the Tbx5/Osr1/Pcsk6 gene interaction was 
associated with atrial septal defects through the signaling 
network (Zhang et al., 2016). Studies have also shown that 
gene‐by‐gene interactions can alter the risk of CTDs among 
human populations. For example, physical interactions 
were found between particular combinations of GATA4 and 
TBX5 molecules, with varying frequencies between families 
with and without cardiac septal defects (Garg et al., 2003). 
It was also suggested that additional gene‐by‐gene inter-
actions might exist between MYH6 and TBX5 (Chen et al., 
2017), MYH6 and NKX2‐5 (Granados‐Riveron et al., 2012), 
and ZFPM2 and GATA4 (Zhang et al., 2014). These studies 
might have provided potential explanations in terms of the 
complex pathophysiological and etiological processes that 
result in CTDs, and also support that gene‐by‐gene interac-
tions are a common mechanism contributing to the disease 
development.
In this study, we evaluate the potential gene‐by‐gene in-
teractions among 13 candidate genes selected from three 
biological pathways (i.e., folate, homocysteine, and trans-
sulfuration) that have altered metabolites in CHD‐affected 
pregnancies (Hobbs, Cleves, Zhao, Melnyk, & James, 2005; 
Hobbs et al., 2006; Kapusta et al., 1999; Obermann‐Borst et 
al., 2011). A total of 515 common variants from 13 genes 
were analyzed in two independent samples, including a se-
quencing study with 328 case‐parental triads and a microar-
ray study with 86 case‐parental triads. The analysis results 
from two independent samples were further integrated by a 
fixed‐effect meta‐analysis.
2 |  MATERIALS AND METHODS
2.1 | Ethics statement
The study was approved by the Institutional Review Boards 
at University of Arkansas for Medical Sciences and Indiana 
University Bloomington, and the National Birth Defects 
Prevention Study (NBDPS) with protocol oversight by the 
Centers for Disease Control and Prevention (CDC) Center 
for Birth Defects and Developmental Disabilities. All study 
subjects gave informed consent. For minors, informed writ-
ten consent was obtained from their legal guardian for DNA 
collection.
2.2 | Study population
The National Birth Defects Prevention Study (NBDPS) is a 
large population‐based, case‐control study of birth defects. 
The detailed study design and procedure has been described 
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elsewhere (Gallagher et al., 2011; Rasmussen et al., 2002; 
Yoon et al., 2001). Briefly, since 1997, subjects have been re-
cruited from the population‐based birth defects surveillance 
system in ten states (i.e., AR, CA, GA, IA, MA, NC, NJ, NY, 
TX, and UT). The study covers an annual birth population of 
482,000 (i.e., 10% of U.S. births). Case infants were identified 
if presenting at least 1 major birth defect. Only non‐syndro-
mic cases were included, and cases with known single gene 
defects or chromosomal abnormalities were excluded. Case 
information and medical records were obtained by trained 
specialists. All diagnostic tests were reviewed by pediatric 
cardiologists to ensure uniform criteria for diagnoses. Study 
information was collected from recruited mothers via com-
puter‐assisted telephone‐interviews with detailed questions 
about environmental exposures. After the interview, a buccal 
cell collection kit was sent to collect biological samples of 
both biological parents and the infant. The collected buccal 
cells were sent back to NBDPS laboratories for DNA extrac-
tion and genotyping.
In our current study, we adopt the case‐parental triad 
design. A case‐parental triad is defined as a singleton live‐
born infant with CTDs and his/her biological parents. Only 
complete triads with genetic data available for three family 
members were included in our study. Subjects in the se-
quencing study was genotyped using Illumina's targeted se-
quencing technology, while those in the microarray study 
were genotyped in one of our earlier studies using Illumina® 
GoldenGate™ platform (Hobbs et al., 2014). The human ref-
erence genome is version GRCh37.p13.
2.3 | Sequencing study
The sequencing study included 328 case‐parental triads. Each 
subject was sequenced for 13 targeted regions, including 
exons, introns, and 1kb upstream and downstream regions for 
the following folate‐related genes: GCLC (OMIM: 606857), 
SHMT1 (OMIM: 182144), NOS2A (OMIM: 163730), MTRR 
(OMIM: 602568), MTHFS (OMIM: 604197), GLRX (OMIM: 
600443), DNMT3A (OMIM: 602769), SOD2 (OMIM: 
147460), MGST1 (OMIM: 138330), GPX4 (OMIM: 138322), 
TCN2 (OMIM: 613441), MTHFD2 (OMIM: 604887), and 
TYMS (OMIM: 188350). These genes were selected for se-
quencing based on a preliminary analysis of data from an 
earlier study (Hobbs et al., 2014). The 13 selected genomic 
regions are described in Table 1. DNA was extracted in ac-
cordance with well‐established NBDPS protocols. Extracted 
DNA (50 ng per sample) was prepared for targeted sequenc-
ing using Illumina Nextera hybridization enrichment. Target 
libraries were pooled at 48x and sequenced on a HiScan‐SQ 
or NextSeq500.
2.4 | Microarray study
The microarray study included 86 case‐parental triads that 
are non‐overlapping subjects with the sequencing study. 
These subjects are NBDPS participants in one of our previ-
ous studies (Hobbs et al., 2014). Each subject was initially 
genotyped for about 1,500 genetic variants in 62 candidate 
genes, including the 13 genes that were included in the se-
quencing study. Illumina's GoldenGate Custom DNA micro-
array was used for genotyping. The detailed process of SNP 
selection, DNA extraction and genotyping can be found else-
where (Hobbs et al., 2014).
2.5 | Quality control
Thirty‐one samples from the sequencing study were also 
genotyped by Illumina HumanOmni 5M BeadChip as part 
T A B L E  1  Candidate genes or regions sequenced in this studya
Genes Region of SNPs Total (kb) Number of SNPs Pathways
DNMT3A chr2: 25,451,420–25,568,539 117.1 45 Homocysteine
MTHFD2 chr2: 74,423,130–74,449,302 26.2 10 Folate
MTRR chr5: 7,846,305–7,908,359 62.0 46 Homocysteine
GLRX chr5: 95,148,650–95,164,023 15.4 9 Transsulfuration
GCLC chr6: 53,357,360–53,414,706 57.3 37 Transsulfuration
SOD2 chr6: 160,091,691–160,119,427 27.7 29 Transsulfuration
MGST1 chr12: 16,492,829–16,533,128 40.3 41 Transsulfuration
MTHFS chr15: 80,130,515–80,198,784 68.3 78 Folate
SHMT1 chr17: 18,222,647–18,274,323 51.7 91 Folate
NOS2A chr17: 26,075,524–26,131,931 56.4 31 Transsulfuration
TYMS chr18: 655,999–680,838 24.8 34 Folate
GPX4 chr19: 1,100,976–1,109,213 8.2 10 Transsulfuration
TCN2 chr22: 31,001,072–31,029,898 28.8 54 Folate
aHuman reference genome version is GRCh37.p13. 
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of another project (unpublished data). Genotype calls were 
compared at 196 overlapping sites, and the concordance rate 
across platforms was 99.0%, indicating high accuracy of vari-
ant calls. All samples were screened for Mendelian inconsist-
encies using PLINK (Purcell et al., 2007). A cell‐line from 
the 1,000 Genome project (Siva, 2008) was sequenced as a 
positive control and was used as an external quality assur-
ance (EQA) measure for NBDPS. In the sequencing study, 
all SNPs had a call rate greater than 95%, and all families 
and SNPs showed Mendelian error rates less than 5%. All 
genotypes with Mendelian inconsistency were set to missing.
2.6 | Imputation and SNP selection
The targeted sequencing provided genotypes for 9,402 vari-
ants in the sequencing study. However, only 74 of those 
variants were readily available in the microarray study. In 
order to maximize the overlap of variants between two stud-
ies, we further conducted genotype imputation for each study 
by using 1,000 Genome Project Phase 3 Genome Build b37 
as reference panels. Software IMPUTE version 2 was used 
for the imputation with a “multi‐population reference panels” 
option (Howie, Donnelly, & Marchini, 2009), which chooses 
a “custom” reference panel for each individual based on all 
available reference haplotypes. The advantages for such a 
strategy has been discussed elsewhere (Howie, Marchini, & 
Stephens, 2011). After the imputation and quality control, the 
sequencing study and the microarray study included 9,588 
and 3,505 variants, respectively. A total of 2,945 variants 
overlapped between two studies. In this article, we only con-
sidered 515 common variants with at least 5% minor allele 
frequencies in both studies for interaction analysis. We ex-
cluded variants with an allele frequency of less than 5% due 
to the limited statistical power for detecting potential interac-
tions among rare variants.
2.7 | Statistical methods
2.7.1 | Single‐locus association test
We first evaluated the association between each genetic vari-
ant and CTD risk with a genotypic transmission disequilib-
rium test (TDT) (Schaid, 1996, 1999). Conditional logistic 
regression model was fitted assuming additive inheritance. 
The conditional probability of disease risk was modeled 
by contrasting affected case infants with the corresponding 
pseudo‐controls whose allele combinations are theoretically 
possible but not observed based on Mendelian transmission 
of given parents’ genotypes (Falk & Rubinstein, 1987). A 
major advantage of using matched pseudo‐controls is its ro-
bustness to confounding causes of association, such as popu-
lation stratification (Cordell, 2002). Such a strategy has been 
commonly used for studies of other birth defects, such as cleft 
palate (Liu et al., 2018, 2019; Xiao et al., 2017). We used 
genotypic TDT instead of conventional allelic TDT to have 
consistent modeling with the interaction analysis described 
below. The genotypic TDT analysis was performed in R ver-
sion 3.43 using Bioconductor package “trio” (Schwender et 
al., 2014).
2.7.2 | Gene‐by‐gene interaction
Our study included 13 candidate genes (Table 1), lead-
ing to a total of 78 gene‐by‐gene combinations. For each 
given gene‐by‐gene combination, we estimated the inter-
action effect for all possible SNP pairs within two respec-
tive genes. We denote pi as the conditional probability 
of being a case infant rather than the pseudo‐controls for 
the i‐th family; and XAi and XBi to be the genotype of two 
SNPs from two respective genes, coded as minor allele 
counts. A conditional logistic regression model was fitted 
as follows:
The model conducted matched case‐control analysis by 
contrasting the affected infants with all possible pseudo‐con-
trols assuming additive inheritance. For single bi‐allelic vari-
ant, two heterozygous parents can produce four inheritance 
patterns of genotypes, suggesting 1 case versus 3 matched 
pseudo‐controls. Similarly, two bi‐allelic variants lead to 16 
two‐SNP inheritance patterns. The ratio between cases and 
their pseudo‐controls is 1:15. The interaction effect between 
two variants can thus be tested against the null hypothesis 
of  =0. The same model was fitted for both the sequenc-
ing study and the microarray study. The analysis was con-
ducted in R version 3.43 using Bioconductor package “trio” 
(Schwender et al., 2014).
2.7.3 | Meta‐analysis
We further conducted a fixed‐effect meta‐analysis in order to 
integrate the results from the sequencing and the microarray 
studies. Top associations were selected based on the signifi-
cance of meta‐analysis (i.e., p‐values) and the consistency of 
testing results across two studies, that is, achieving nominal 
significance level in both studies and having the same direc-
tion of effect. The analysis was conducted in R version 3.43 
using package “rmeta.”
2.7.4 | Multiple testing adjustment
A total of 118,757 SNP pairs were tested for possible interac-
tion effects. Because of the strong linkage‐disequilibrium (LD) 
structure within the same candidate genes (Fig. S1), the con-
ventional Bonferroni correction would be overly conservative. 
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effective number of independent tests among highly correlated 
data (Gao, Starmer, & Martin, 2008) and applied a Bonferroni 
correction based upon this estimate. The details and advan-
tages of SimpleM has been discussed elsewhere (Gao, Becker, 
Becker, Starmer, & Province, 2010). In particular, SimpleM 
uses principal component analysis to estimate the effective 
number of independent tests while accounting for the majority 
of genetic variation (e.g., 95%). All analyses were performed 
using R version 3.4.3.
3 |  RESULTS
The demographic information of our study populations is 
summarized in Table 2. A total of 328 and 86 case‐parent 
triads were included in the sequencing and the microarray 
studies, respectively. Most of the maternal characteristics, 
including race, body mass index, education level, folic acid 
supplementation, alcohol use and smoking status, were simi-
lar between two studies (i.e., p‐values > .05). The average 
maternal age at delivery was 28.31 and 30.03 years in the 
sequencing and the microarray studies, respectively, which 
were statistically different but not of clinical importance. 
Family income levels were also statistically different be-
tween two studies, which may largely due to the high level 
of missing values in the sequencing study. In both studies, 
the most frequent maternal characteristics were Caucasian 
race, normal body mass index (BMI), and over 16  years 
of education. The majority of the families had more than 
$50,000 annual household income. In terms of maternal life-
style factors, more women were taking folic acid supple-
mentation regularly during the pregnancy, and less women 
smoking or drinking.
3.1 | Single‐locus association test
Each of 515 SNPs was examined using a genotypic TDT as 
described above. The testing p‐values are shown in Figure 1. 
The multiple testing significance thresholds were calculated 
as 0.05/144 = 3.5*10−4, where the effective number of in-
dependent tests estimated by SimpleM was 144. In addition, 
results for each gene were summarized in Table 3. None of 
the associations remained significant after multiple testing 
adjustment.
3.2 | Gene‐by‐gene interaction
Each SNP pair was examined using a conditional logistic 
regression model described above. Under the null hypoth-
esis of no association, the testing p‐values were expected 
to follow a uniform distribution, and the distribution was 
evaluated by a quantile‐quantile (QQ) plot (Fig. S2). No 
early departure from the uniform distribution was found, 
with genomic inflation factors (λ) close to 1, suggest-
ing no inflated type I error rate. The top 5 SNP pairs are 
summarized in Table 4. In particular, the interaction ef-
fect between rs4764267 and rs6556883, located in genes 
MGST1 and GLRX, respectively, had an adjusted p‐value 
of .04, which remained significant after multiple testing 
adjustment. The interaction effect and corresponding gen-
otypic relative risks varied largely between two studies, 
which we attributed mainly to the small sample size of our 
microarray study. These two SNPs may form 9 possible 










Mean (SD) 28.31 (6.00) 30.03 (6.21) .022
Maternal race, n (%)     .604
Caucasian 233 (71.04%) 68 (79.07%)  
African American 19 (5.80%) 3 (3.49%)  
Hispanic 52 (15.85%) 10 (11.63%)  
Others 24 (7.32%) 5 (5.81%)  
Maternal BMI, n (%)     .161
Underweight 14 (4.27%) 2 (2.32%)  
Normal 147 (44.82%) 53 (61.73%)  
Overweight 81(24.70%) 16 (18.60%)  
Obese 76 (23.17%) 15 (17.44%)  




0–11 years 35 (10.67%) 7 (8.14%)  
12 years 72 (16.77%) 19 (22.09%)  
13–15 years 100 (30.49%) 21 (24.42%)  
16 or more years 121 (36.89%) 36 (41.86%)  
Missing 0 (0.00%) 3 (3.49%)  
Family Income, n (%)     .004
< 10,000 34 (10.36%) 9 (10.46%)  
10,000 to 30,000 55 (14.78%) 15 (17.44%)  
30,000 to 50,000 41 (12.50%) 13 (15.12%)  
> 50,000 62 (18.90%) 46 (53.49%)  




193 (58.84%) 49 (56.98%) .755
Maternal Alcohol Use, 
n (%)
92 (28.05%) 33 (38.37%) .063
Maternal Smoke,  
n (%)
44 (13.41%) 16 (18.60%) .211
Missing 1 (0.30%) 1 (1.16%)  
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two‐SNP genotype combinations. We estimated the rela-
tive risks among these genotype combinations formed 
by rs4764267 and rs6556883 (Table 5). To illustrate the 
interaction effect of these two SNPs, we further plotted 
these estimated relative risks in Figure 2. When genotype 
GG was observed at SNP rs6556883 (i.e. red line), allele 
T at SNP rs4764267 was estimated to increase the dis-
ease risk compared to allele G. However, when genotype 
AG or AA was observed at SNP rs6556883 (i.e. green 
and blue lines), allele T at SNP rs4764267 was expected 
to decrease the disease risk but with varying effect size. 
Such a pattern remained consistent across the two studies. 
SNPs rs4764267 and rs6556883 were located within genes 
MGST1 and GLRX, respectively. The other four SNP pairs 
in Table 4 were from the same gene pairs of DNMT3A 
and MTRR, and were in strong LD. We believe these four 
SNP pairs were representing the same gene‐by‐gene in-
teraction. In particular, the SNP pair of rs11892646 and 
rs56219526 was marginally significant after multiple test-
ing adjustments (p‐value = .06). We presented the analysis 
results in Table 6, and illustrated the relative risk among 
genotype combinations in Figure 3.
4 |  DISCUSSION
In this study, we conducted a two‐phase investigation to 
evaluate the possible interactions among 13 candidate 
genes for association with CTD risk. One SNP pair (i.e., 
rs4764267 and rs6556883) was identified with a signifi-
cant p‐value after multiple testing adjustment, and an-
other SNP pair (i.e., rs11892646 and rs56219526) was 
marginally significant. All identified genes are function-
ally involved in the transsulfuration pathway, supporting 
its possible contribution to the genetic susceptibility of 
CTDs.
Our results are consistent with previous work. Gene 
MGST1 encodes microsomal glutathione S‐transferase 
1, which contributes to the antioxidant system by cata-
lyzing glutathione binding to toxic electrophilic com-
pounds. Decreased expression of MGST1 has been linked 
structural cardiac abnormalities in Nos3 deficient mice 
(Campbell, Li, Biendarra, Terzic, & Nelson, 2015). 
GLRX encodes glutaredoxin‐1, which catalyzes the glu-
tathione regeneration and provides reactant for MGST1, 
and is also involved in the response to oxidative stress. 
Overexpression of GLRX2 in transgenic mice has been 
found to attenuate doxorubicin (DOX)‐induced heart de-
fects (Diotte, Xiong, Gao, Chua, & Ho, 2009). Others and 
we have previously reported the association of polymor-
phisms in MGST1 and GLRX with CHDs in other NBDPS 
samples although the molecular mechanism remains un-
clear (Chowdhury et al., 2012; Nembhard et al., 2017, 
2018). Meanwhile, accumulated evidence suggests that 
the oxidative stress/transsulfuration pathway plays an es-
sential role in cardiac pathogenesis. For example, others 
and we have shown differences in markers of oxidative 
stress, including glutathione level, among women with 
infants affected by CHDs compared to those with healthy 
infants (Hobbs et al., 2005). In addition, decreased activ-
ity of antioxidant enzyme such as glutathione peroxidase 
and lower levels of molecular antioxidants were observed 
among children affected by CHDs compared to healthy 
controls (Mukhopadhyay, Gongopadhyay, Rani, Gavel, & 
F I G U R E  1  Barplot of single‐locus 
genotypic TDT test from meta‐analysis. 
No significant findings after multiple 
testing adjustment. Each bar represents the 
negative 10‐based logarithm of p‐value for 
a SNP, ordered by its physical location in 
the genome. The dashed line represents the 
threshold of statistical significance after 
multiple testing adjustment
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Mishra, 2015; Rokicki, Strzalkowski, Klapcinska, Danch, 
& Sobczak, 2003). Moreover, animal studies showed that 
oxidative stress might explain the increased risk of CHDs 
among female mice with diabetes (Wang, Reece, & Yang, 
2015; Wu et al., 2016). In terms of the genes DNMT3A 
and MTRR, evidence suggest their association with CHD, 
respectively, in both animal models (Deng, Elmore, 
Lawrance, Matthews, & Rozen, 2008; Feng et al., 2013) 
and population‐based case‐control studies (van Beynum 
et al., 2006; Shaw et al., 2009; Sheng et al., 2013). It is 
also biologically plausible that MTRR and DNMT3A may 
interact functionally since they work sequentially in ho-
mocysteine‐methionine cycle (Ly, Hoyt, Crowell, & Kim, 
2012).
In our study, a few assumptions were made while 
evaluating the possible interactions. First, by contrast-
ing the affected infants with pseudo‐controls, we as-
sumed that these theoretically possible but unobserved 
siblings were healthy individuals. Such an assumption 
is in general reasonable since CTDs are a relative rare 
T A B L E  3  Results of single‐locus genotypic TDT test for each genea
Gene SNP Chro Position Study Estimate (SE) 95% CI p‐value Adjusted p‐value









































































































































































aEstimates are exponential of β coefficients, representing relative risks. SNPs were ordered based on adjusted p values. 
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disease with around 0.1% prevalence in the general pop-
ulation (Zhang, Li, et al., 2018b). Second, additive mode 
of inheritance was assumed when estimating the genetic 
effects, which is commonly used in genetic association 
studies.
The current analysis has several strengths. First, it is 
robust to population stratification and other environmen-
tal confounders as a result of case‐parent design and use 
of conditional logistic regression model. Second, it inte-
grates data from two studies to replicate results and achieve 
greater power. Third, we have optimized statistical power 
by including only common variants in the analysis. The 
study is limited by modest sample size, which reduces 
T A B L E  4  Top 5 gene‐by‐gene interaction by conditional logistic regressiona
Gene Pair
SNP










































































































aEstimates are exponential of β coefficients, representing relative risks. 
bAdjusted p‐values were marked with **if less than .05 and marked with *if less than .1. 







GG GG 1.00 (ref) 1.00 (ref)
TG GG 1.70 (1.23, 2.36) 1.73 (0.77, 3.91)
TT GG 2.89 (1.51, 5.56) 3.01 (0.59, 15.28)
GG AG 1.55 (1.04, 2.31) 4.38 (1.59, 12.08)
TG AG 1.29 (0.83, 2.02) 1.84 (0.54, 6.24)
TT AG 1.08 (0.54, 2.18) 0.78 (0.11, 5.40)
GG AA 2.41 (1.08, 5.35) 19.19 (2.53, 145.84)
TG AA 0.98 (0.49, 2.00) 1.96 (0.27, 14.20)
TT AA 0.40 (0.14, 1.19) 0.20 (0.01, 4.67)
aEstimates are relative risks and 95% confident intervals. 
F I G U R E  2  Estimated relative risk of CTD among all genotypic 
combinations of rs4764267 and rs6556883: (a) is for sequencing study 
and (b) is for microarray study
(a)
(b)
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statistical power for epistasis detection. However, this is 
the one of the largest studies to investigate the gene‐by‐
gene interaction and the risk of conotruncal heart defects.
5 |  CONCLUSION
We identified two gene‐by‐gene interactions that are poten-
tially associated with conotruncal heart defects. The genes 
are involved in transsulfuration pathways. Further studies 
with larger sample sizes are needed to confirm the associa-
tions. While we provide a possible explanation of their in-
teractions, these explanations are our speculations based on 
existing knowledge. Additional molecular studies are needed 
to elucidate the molecular mechanisms of this hypothesis.
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